Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Flu Vaccines
Study findings from A.R. Falsey et al provide new insights into flu vaccines
November 26th, 2008
"Respiratory syncytial virus (RSV) has been recognized recently as an important adult pathogen. This randomized, double-blind, placebo-controlled study was designed to compare humoral responses to licensed trivalent influenza vaccine given concomitantly with 1 of 2 RSV vaccine formulations in persons >= 65 years old with cardiopulmonary disease," scientists writing in the Journal of Infectious Diseases report. "Hemagglutinin-inhibition assays and neutralization assays were used to measure levels of antibody to influenza and RSV, respectively. Subjects with respiratory illnesses during subsequent winters were tested for RSV and influenza by...
Source: Vaccine Weekly (2008-11-26)
|
